Biochemical, biological and structural properties of romidepsin (FK228) and its analogs as novel HDAC/PI3K dual inhibitors

Romidepsin (FK228, depsipeptide) is a potent histone deacetylase (HDAC) inhibitor that has FDA approval for the treatment of cutaneous and peripheral T-cell lymphomas. We have previously reported that FK228 and its analogs have an additional activity as phosphatidylinositol 3-kinase (PI3K) inhibitor...

Descripción completa

Detalles Bibliográficos
Autores principales: Saijo, Ken, Imamura, Jin, Narita, Koichi, Oda, Akifumi, Shimodaira, Hideki, Katoh, Tadashi, Ishioka, Chikashi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BlackWell Publishing Ltd 2015
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4399029/
https://www.ncbi.nlm.nih.gov/pubmed/25492515
http://dx.doi.org/10.1111/cas.12585

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4399029/
https://www.ncbi.nlm.nih.gov/pubmed/25492515
http://dx.doi.org/10.1111/cas.12585

Ejemplares similares